Program areas at Sean N. Parker Foundation
Films - the Foundation financed two documentary films. The first film, of medicine and miracles (formerly titled trial by fire), debuted at the tribeca film festival and is a documentary about contemporary immunotherapy cancer fighting treatments. Through this film, the Foundation aims to raise public awareness about immunotherapy to drive support for this kind of cancer research and to encourage more patients to seek out such clinical trials in furtherance of both scientific advancement and improvements in health care. The second film, coming clean, focuses on the opioid addiction crisis in america. Both films honor the difficult experiences of their subjects, while empowering future generations to strive for transformational improvements. The films further charitable and educational purposes by supporting artistic endeavors and by helping to educate the public about critical health issues. The films further the Foundation's specific charitable goals in the area of life sciences.
Artwork - the artworks in the Foundation's collection are held in trust for the public and made available for public display, research, and education. To advance this mission, the Foundation places its artwork on rotating loans to various museums both in and outside the united states and encourages the museums to include educational programming around the loaned works, such as curatorial lectures, public programs, and symposia. When not on loan, the works are stored at a specialized art facility that preserves the art for future generations and allows students and scholars to conduct research.
Institute for immunology and immunotherapy - to further the Foundation's charitable goals related to life sciences, the Foundation helped to incubate the launch of the institute for immunology and immunotherapy. The Foundation's president, mr. Parker, and five other founders recognized that recent scientific advances created opportunities to apply immunological research to treat cardiovascular disease, allergies, neurological conditions, and autoimmune diseases. Moreover, the covid-19 pandemic made immunological research all the more compelling and urgent, as scientists work to better prepare for future pandemics. The Foundation paid for initial legal services and related startup expenses that enabled this project to advance towards securing a fiscal sponsor and eventually securing its own exemption.